Ovarian Epithelial Tumor

About
Mappings

OncoTree: Ovarian Epithelial Tumor (oncotree:OVT)

Therapeutic response

Precision oncology relationships for therapeutic response involving this cancer type.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Niraparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Niraparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Rucaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Rucaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Rucaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Rucaparib
Sensitivity (+) FOLR1 positive Ovarian Epithelial Tumor Mirvetuximab soravtansine
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) HRD Ovarian Epithelial Tumor Bevacizumab, Olaparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA1 pathogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 oncogenic variants Ovarian Epithelial Tumor Olaparib
Sensitivity (+) BRCA2 pathogenic variants Ovarian Epithelial Tumor Olaparib